Institute of Medicine (U.S.). Forum on Drug Discovery, D., Institute of Medicine (U.S.). Board on Health Sciences Policy., National Academies Press (U.S.), ProQuest (Firm), Weisfeld, N. E., English, R. A., & Claiborne, A. B. (2012). Envisioning a transformed clinical trials enterprise in the United States: Establishing an agenda for 2020: workshop summary. Washington: National Academies Press.
Chicago Style CitationInstitute of Medicine (U.S.). Forum on Drug Discovery, Development, Institute of Medicine (U.S.). Board on Health Sciences Policy, National Academies Press (U.S.), ProQuest (Firm), Neil E. Weisfeld, Rebecca A. English, and Anne B. Claiborne. Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary. Washington: National Academies Press, 2012.
MLA CitationInstitute of Medicine (U.S.). Forum on Drug Discovery, Development, et al. Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary. Washington: National Academies Press, 2012.